Inventor
SWANSON BARBARA A
US23 patents
⚠️ This page may combine multiple inventors who share the name “SWANSON BARBARA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SORRENTO THERAPEUTICS INC
18 patentsUS10058609B2Aug 28, 2018
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC17 citations93
US9676853B2Jun 13, 2017
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC15 citations92
US10035855B2Jul 31, 2018
Antibody therapeutics that bind CD47
SORRENTO THERAPEUTICS INC8 citations84
US10377827B2Aug 13, 2019
Antigen binding proteins that bind c-met
SORRENTO THERAPEUTICS INC14 citations83
US10584168B2Mar 10, 2020
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC1 citations72
US9315579B2Apr 19, 2016
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC3 citations71
US10435476B2Oct 8, 2019
Antibody therapeutics that bind JAG1
SORRENTO THERAPEUTICS INC4 citations68
US11878058B2Jan 23, 2024
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11242391B2Feb 8, 2022
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11155628B2Oct 26, 2021
Antigen binding proteins that bind c-Met
SORRENTO THERAPEUTICS INC0 citations60
US10696746B2Jun 30, 2020
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC0 citations51
US9951138B2Apr 24, 2018
Antigen binding proteins that bind CCR2
SORRENTO THERAPEUTICS INC0 citations51
US9944707B2Apr 17, 2018
Antibodies that bind epidermal growth factor receptor (EGFR)
SORRENTO THERAPEUTICS INC1 citations51
US10668148B2Jun 2, 2020
Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereof
SORRENTO THERAPEUTICS INC0 citations50
US10479837B2Nov 19, 2019
Methods for treating subjects having a CXC chemokine receptor 5 (CXCR5)-responsive cancer by administering fully human anti-CXCR5 antibodies
SORRENTO THERAPEUTICS INC0 citations50
US9765145B2Sep 19, 2017
Fully human anti-C-X-C chemokine receptor 3 (CXCR5) antibodies
SORRENTO THERAPEUTICS INC0 citations50
US9765146B2Sep 19, 2017
Fully human anti-CXC chemokine receptor 5 (CXCR5) antibodies
SORRENTO THERAPEUTICS INC1 citations50
GENENCOR INT
4 patentsUS6080568AJun 27, 2000
Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
GENENCOR INT28 citations92
US6599722B2Jul 29, 2003
Method for producing ascorbic acid intermediates
GENENCOR INT42 citations86
US6458928B1Oct 1, 2002
Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins
GENENCOR INT5 citations73
US6967246B2Nov 22, 2005
Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins
GENENCOR INT4 citations62